PROGRESSIVE VETERINARY ASSOCIATION
Company number 13061868 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
PROGRESSIVE VETERINARY ASSOCIATION - Analysis Report
Company Number: 13061868
Analysis Date: 2025-07-20 13:31 UTC
Financial Health Assessment for PROGRESSIVE VETERINARY ASSOCIATION
1. Financial Health Score: D
Explanation:
The company shows persistent negative net current assets and net liabilities, indicating a fragile financial condition with tight liquidity. Although the negative position has improved from previous years (from -£803 in 2022 to -£17 in 2023), the company is still technically insolvent on a balance sheet basis. The minimal cash reserves relative to current liabilities signify ongoing symptoms of financial distress, although there is a slight improvement trend.
2. Key Vital Signs
| Metric | 2023 Value | Interpretation |
|---|---|---|
| Cash at bank | £1,964 | Low cash reserves, but improved from £967 in 2022, showing modest strengthening of liquidity. |
| Current Liabilities | £1,981 | Short-term debts are nearly equal to cash, indicating tight working capital and potential cash flow issues. |
| Net Current Assets | -£17 | Slightly negative working capital ("negative pulse"), meaning current liabilities exceed current assets. |
| Net Assets (Equity) | -£17 | Negative equity ("balance sheet anemia"), indicating liabilities exceed assets by a small margin. |
| Trend in Net Current Assets | Improved from -£803 (2022) to -£17 (2023) | Indicates some recovery but still fragile financial health. |
| Number of Employees | 0 | No employees; this might indicate minimal operational activity or outsourcing, impacting revenue sustainability. |
3. Diagnosis
The company is exhibiting symptoms of financial stress, primarily due to negative working capital and negative equity. Negative net current assets mean that the company does not have sufficient short-term resources to cover its immediate obligations, which could impair its operational capability if not addressed. The improvement from -£803 to -£17 in net current assets over one year is a positive sign, suggesting some management effort to stabilize finances or reduce liabilities.
However, the company's cash reserves remain very low relative to liabilities, akin to a patient with a weak but slightly improving heartbeat—there is life, but vulnerability remains. The absence of employees could imply the company is either in a start-up phase, operating with contractors, or not fully active in generating revenue, which could constrain cash inflows further.
Given the company's status as a private limited company limited by guarantee and its veterinary activities, it may rely on member funding or external support rather than traditional share capital, which may explain the negative equity position.
4. Recommendations
To improve the financial health and strengthen the company’s financial "immune system," the following steps are recommended:
Increase Liquidity:
Explore options to boost cash reserves, such as securing short-term funding, member contributions, or increasing revenue-generating activities. Healthy cash flow is vital to cover immediate liabilities and avoid insolvency risks.Manage Liabilities:
Negotiate extended payment terms with creditors or reduce short-term debts to restore positive net current assets, improving the company's working capital position.Revenue Enhancement:
If the company is not fully operational, consider strategies to ramp up veterinary activities or related services to generate sustainable income streams that can support operational costs.Cost Control:
With no employees, ensure that operational costs are tightly managed. If employees are to be hired, plan cash flow accordingly to avoid exacerbating liquidity issues.Regular Monitoring:
Implement frequent financial health checks (quarterly) to catch early warning signs of distress and address them proactively.Engage Professional Advice:
Given the delicate financial condition, consulting with financial advisors or turnaround specialists could help design a sustainable business model and financial structure.
Medical Analogy Summary
The company currently presents with a weak but improving "financial pulse"—its working capital has nearly normalized, but the "balance sheet anemia" (negative equity) indicates it is still not in robust health. Without intervention to strengthen liquidity and generate consistent revenue, the risk of financial "complications" such as inability to meet liabilities remains.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.